DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Haas M, Boeck SH, Siveke JT. et al.
Efficacy of gemcitabine with erlotinib in rash-positive patients selected according to eligibility for FOLFIRINOX.
J Clin Oncol 2017;
35: 4108
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.